CompoAtlas

Bactro Plex

Bactro Plex, licence 80071539: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Natural Equivalents Incorporated
NPN or DIN-HM
80071539
Status
Inactive licence
Licence date
29 July 2016
Revision date
Not provided
Form
Gouttes orales
Route of administration
Orale
Application type
Homéopathique

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Botulinum

Source : Bactéries isolées de nourriture contaminée

13.0 CHNot calculated
Colibacillinum

Source : Escherichia coli

10.0 XNot calculated
Pneumococcinum

Source : Bactéries extraites de la salive, la muqueuse nasale, le pharynx et la conjonctive de personnes saines

13.0 CHNot calculated
Proteus

Source : Enterobactéries isolées des patients souffrant d'infection des voies urinaires et de gastro-entérite

13.0 CHNot calculated
Pseudomonas aeruginosa

Source : Pseudomonas aeruginosa

13.0 CHNot calculated
Salmonella typhi

Source : Lavages d'une culture de Salmonella typhi

13.0 CHNot calculated
Scarlatinum

Source : Bactéries entières provenant des humains, des animaux, de l'épiderme ou de l' air

13.0 CHNot calculated
Staphylococcinum

Source : Derivé d'une culture mixte de de Staphyloccocus epidermidis, Shaphylococcus haemolyticus et Staphylococcurs simulans.

13.0 CHNot calculated
Streptococcinum

Source : Cultures pures de Streptococcus pyogenes sans agents antimicrobiens

13.0 CHNot calculated
Tuberculinum

Source : Solution derivée des produits solubles concentrés de culture du bacille tuberculeux (Mycobacterium tuberculosis)

13.0 CHNot calculated
Hydrastis canadensis

Source : Rhizome et racine(s)

8.0 XNot calculated

Non-medicinal ingredients

Lactose, Eau, Éthanol

PopulationAgeQuantity per servingFrequency
Adultes et adolescentsminimum: 13.0 Année(s)10.0 Goutte(s)3.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Nosodes Medicine.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80071539

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line